News and Information Related to Women's Health Issues. Learn about hormones, birth control, pregnancy, menopause, breast exams and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Testosterone Injections Offer Hope for Male Contraceptive

Possible alternative to current birth control methods needs more study

TUESDAY, May 5 (HealthDay News) -- Injectable testosterone may be an effective form of male contraception, new research suggests.

Chinese researchers injected 1,045 healthy, fertile Chinese men aged 20 to 45 years with a 500 milligram formulation of testosterone undecanoate in tea seed oil once a month for 30 months.

Advertisement
Related Stories
 border=
Casual Sex Can Lead to Long-Term Relationships: Study
Babies Born Late May Face Small Cerebral Palsy Risk
Preventive Surgeries May Be Lifesaver for Women at High Cancer Risk
Related Videos
 border=
How Do I Find a Good Bra Post-Mastectomy?
How Do I Deal with Hair Loss After Chemotherapy for Breast Cancer?
How Do I Talk to My Doctor About Medical Options After a Breast Cancer Diagnosis?
Related Slides
 border=
Pelvic Inflam Disease
Placenta Abruptio
PMS
Related Encyclopedia
 border=
Amenorrhea
Amniocentesis
Amniocentesis and CVS


All of the study participants had a normal medical history and had fathered at least one child within two years of beginning the study. The female partners of the study participants, aged 18 and 38 years, also had normal reproductive function.

Results showed a contraceptive failure rate of 1.1 per 100 men in the 24-month efficacy phase, resulting in pregnancy. The researchers noted that no serious adverse events were reported in any of the men and, in all but two men, reproductive function returned to the normal fertile reference range.

"For couples who cannot, or prefer not to use only female-oriented contraception, options have been limited to vasectomy, condom and withdrawal," said Dr. Yi-Qun Gu, of the National Research Institute for Family Planning in Beijing, China. "Our study shows a male hormonal contraceptive regimen may be a potential, novel and workable alternative."

The study will appear in the June issue of the Journal of Clinical Endocrinology & Metabolism.

This is the largest multi-center, male hormonal contraceptive efficacy clinical trial of an androgen preparation, Gu said in an Endocrine Society news release.

"Despite the present encouraging results, the long-term safety of this hormonal male contraceptive regimen requires more extensive testing with a focus on cardiovascular, prostate and behavioral safety," Gu said.

More information

MaleContraception.org has more on efforts to develop male hormonal contraception, including using testosterone.

-- Jennifer Thomas

SOURCE: The Endocrine Society, news release, May 4, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 5/5/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Sep 3, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Breast Cancer Connection
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: